Healthcare

WHITE PAPERS AND CASE STUDIES

• Flexible Data Management For Growing Portfolio

  Explore strategic enhancements to a small biopharma's biometrics capabilities involving the deployment of 20 specialized professionals, which effectively bolstered the client’s organizational capacity.

• Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing

  For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.

• Patient Diversity: Identifying Challenges, Opportunities, And Best Practices

  By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.

• Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC

  Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

• Standardizing Content Management Across The Life Sciences Industry

  Explore a quality reference model that aims to foster further standardization within the life sciences industry, and discover the advantages of leveraging the standardized best practices within.

• Case Study: Development Of A Plastic Capillary Blood Sampling Device

  This brief paper describes the work undertaken by Axis-Shield PoC A/S and Carclo Technical Plastics to develop an innovative solution, thereby improving an existing product and significantly reducing cost.

• Developing Effective Procedures

  Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system.

• How Syneos Health Tackles Protocol Complexities

  Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.

• The Promise Of PCM: Getting To Maturity

  PCM offers a number of advantages, including streamlined development and increased flexibility. Review the key drivers for PCM as well as the hurdles that stand in the way of industry-wide adoption.

• As Rates Of Uterine Cancer Rise, So Do Racial Disparities In Care And Outcomes

  Learn about several factors that contribute to racial disparities in uterine cancer and how targeted interventions such as increased access to healthcare, improved patient-provider communication, and cultural competency training can ensure equitable and effective healthcare for all patients.

• CHO Cell Lines For Recombinant Protein Production

  Discover how new strategies in CHO cell line development are driving innovation and transforming the future of biologics manufacturing, from enhanced productivity to improved therapeutic quality.

• From Paper To Digital Study Management In Large Patient Registries

  Uncover how this sponsor was able to independently design and oversee its clinical study, minimizing external assistance, and easing the workload for their sites through mobile app accessibility.